Multi-Omics for Maternal Health After Preeclampsia

Description

To develop strategies to identify postpartum women at risk for adverse cardiovascular outcomes and provide them with preventative therapies.

Conditions

Pre-Eclampsia, Pregnancy Induced Hypertension

Talk to us

Study Overview

On this page

Study Details

Study overview

To develop strategies to identify postpartum women at risk for adverse cardiovascular outcomes and provide them with preventative therapies.

Multi-Omics for Maternal Health After Preeclampsia

Multi-Omics for Maternal Health After Preeclampsia

Condition
Pre-Eclampsia
Intervention / Treatment

-

Contacts and Locations

San Diego

University of California, San Diego, San Diego, California, United States, 92037

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Pregnant women 18 years of age to 50 years of age
  • * 10-24 weeks gestation at time of enrollment
  • * Singleton pregnancy
  • * Planning to deliver at a study site (UCSD or VUMC)
  • * Inability to give informed consent
  • * Intrauterine fetal demise
  • * Fetal genetic or structural anomaly
  • * Institutionalization for psychiatric disorder, mental deficiency or incarcerated
  • * Active or history of malignancy requiring major surgery or systemic chemotherapy
  • * Multi-fetal gestation or a twin demise at any gestational age
  • * Known maternal or fetal chromosomal anomalies
  • * Patients who plan to keep their placenta after delivery

Ages Eligible for Study

18 Years to 50 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of California, San Diego,

Louise Laurent, MD, PhD, PRINCIPAL_INVESTIGATOR, UCSD

Marni Jacobs, PhD, PRINCIPAL_INVESTIGATOR, UCSD

Study Record Dates

2028-12